An employee told you they paid less for a prescription by leaving their insurance card in their wallet. You did a double take. That cannot be right. You pay a fortune for that coverage.

You were right to do the double take. It is exactly as backwards as it sounds.

Here is the machine behind it. Between you and the pharmacy sits a pharmacy benefit manager, the PBM, the company that runs your drug plan. They negotiate prices, decide how much of the manufacturer rebates flow back to you, and set what your plan pays. Sometimes the cash price a stranger off the street gets is lower than the “discounted” price your plan pays. The spread does not come back to you. It stays in the middle, with the PBM.

Now put that next to your renewal. Prescription drugs are one of the biggest forces pushing your 2027 number up. GLP-1 medications alone, the weight and diabetes drugs everyone is talking about, are exploding. Filled prescriptions nearly doubled in a year, and nearly eight in ten employers now name them as a top cost driver. Specialty drugs pile on top. A big share of your increase is pharmacy, and a big share of your pharmacy spend is structure you cannot see.

This is where control changes everything. In the plans where we pick the pharmacy manager separately and read the actual contract, we see the spread, we shut down the games, and drug costs come down without touching a single employee’s copay or medication. Same drugs. Same people. Lower cost. In the bundled plans, that math stays hidden on purpose.

Your employee noticing the cash price is not a fluke. It is a crack of daylight into a system built to be confusing.

What to do this fall: ask who your pharmacy manager is, how they get paid, and whether your contract is transparent. A shrug or a word salad is the finding. The people making money on the confusion are counting on you not asking. Want to read the contract yourself? We built an AI prompt that shows you exactly what to flag. Download The Benefits Contract Review Prompt Pack

The pharmacy counter is where your whole plan shows its hand. Read it.

Want to know what your drug plan is really costing you? Let’s talk.

ABOUT THE AUTHOR

Allison De Paoli

Allison De Paoli has been solving the healthcare crisis for employers who were sure there was nothing they could do to control their costs or create a better healthcare experience for their employees.

She co-authored the Amazon Best-Seller Breaking Through the Status Quo: How Innovative Companies are Changing the Benefits Game to Help Their Employees and Boost Their Bottom Line and was recognized as a 2019 Top Woman in Advising by BenefitsPRO.

Her work has since earned additional industry recognition, including Most Effective Benefits Consultant, NextGen Benefits Network Advisor of the Year, YouPowered Most Innovative Healthcare Consultant, and 2026 BenefitsPRO Advisor of the Year.

In 2024, her work and perspective on healthcare were also featured in the documentary It’s Not Personal, It’s Just Healthcare.

Download Instant EBITDA.

Instant EBITDA arms you with the same questions I use to diagnose plans with 100–500 employees. It helps you:

  • See what’s missing
  • Pressure-test your broker and vendors
  • Spot where money is leaking out
  • Understand what “good” looks like